QT
LUMO

Quantbot Technologies’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Quantbot Technologies’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-84
Closed -$8K – 1376
2016
Q2 		$8K Buy
+84
New +$10.4K ﹤0.01% 980
2015
Q4 		– Sell
-278
Closed -$89K – 1435
2015
Q3 		$89K Buy
278
+145
+109% +$63.7K 0.02% 792
2015
Q2 		$53K Buy
+133
New +$56.5K 0.01% 806
2014
Q4 		– Sell
-459
Closed -$88K – 1451
2014
Q3 		$88K Buy
+459
New +$101K 0.01% 887
2014
Q2 		– Sell
-144
Closed -$36K – 1427
2014
Q1 		$36K Buy
+144
New +$44K 0.01% 866

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantbot Technologies's LUMO Position: Q3 2016 in Review

Quantbot Technologies sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2016, closing a stake of 84 shares — an estimated $8K sold.

Quantbot Technologies first reported a position in LUMO in Q1 2014 and held it in 5 quarters. The position peaked at $89K in Q3 2015. 104 funds tracked by Wall St. Rank hold LUMO as of Q3 2016.

  • Quantbot Technologies reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Quantbot Technologies sold 84 Lumos Pharma, Inc. Common Stock shares in Q3 2016, an estimated $8K.
  • Quantbot Technologies first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and held it in 5 quarters.
  • Quantbot Technologies's Lumos Pharma, Inc. Common Stock position peaked at $89K in Q3 2015.
  • 104 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2016.

Based on Quantbot Technologies's 13F filing for Q3 2016, filed 31 Oct 2016.